Celldex Therapeutics, Inc. (CLDX) is in Healthcare, Biotechnology, based in United States, listed on NasdaqCM. Market cap 2.30B USD. 52-week range 22.10 to 45.14 USD. Data as of 2026-10-09.
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently ...